In a week dotted with big news for the life science industries, the passage of 21st Century Cures legislation in the House of Representatives is perhaps the biggest. Investors and industry are understandably enthused at the development, but opponents, including Senate Democrat Elizabeth Warren of Massachusetts, are blasting the legislation as a grab bag for industry that exposes patients to greater risk. (See story this issue.) Read More
